Compare BioNTech SE - ADR (BNTX) vs Blackstone Inc (BX) Price & Performance
Price performance (Past 24H)
Key statistics
Key statistics
BioNTech SE - ADR vs Blackstone Inc — how do they compare? BioNTech SE - ADR trades at $92.8 (market cap $23.31B), while Blackstone Inc trades at $147.84 (market cap $117.44B). The key difference: Blackstone Inc is far larger — about 5× BioNTech SE - ADR's market cap, and Blackstone Inc pays a 3.55% dividend while BioNTech SE - ADR pays none. Which is the better fit depends on your goals.
| BNTX | BX | |
|---|---|---|
Market Cap | $23.31B | $117.44B |
Sector | Health | Financials |
52-Week High | $119.34 | $188.68 |
52-Week Low | $83.89 | $102.12 |
Enterprise Value | $6.60B | — |
Dividend Yield | — | 3.55% |
Returns comparison
Trailing returns across standard periods
Returns comparison
Trailing returns across standard periods
Top news
Latest headlines on both assets
Top news
Latest headlines on both assets
About BioNTech SE - ADR
BioNTech is a Germany-based biotechnology company that focuses on developing cancer therapeutics, including individualized immunotherapy, as well as vaccines for infectious diseases, including COVID-19. The company's oncology pipeline contains several classes of drugs, including mRNA-based drugs to encode antigens, neoantigens, cytokines, and antibodies.
Read more on BNTX →About Blackstone Inc
Blackstone is one of the world's largest alternative asset managers with $940.8 billion in total asset under management, including $683.8 billion in fee-earning asset under management, at the end of June 2022.
Read more on BX →
